Paediatric Respiratory Reviews
Volume 10, Issue 4 , Pages 214-219 , December 2009

Anti-inflammatory drug therapy in asthma

References 

  1. Kay AB. Allergy and allergic diseases. First of two parts. N Engl J Med. 2001;344:30–37
  2. Larche M, Robinson DS, Kay AB. The role of T lymphocytes in the pathogenesis of asthma. J Allergy Clin Immunol. 2003;111:450–464
  3. National Heart Lung and Blood Institute. National Asthma Education and Prevention Program: Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma; 2007.
  4. Global Strategy for Asthma Management and Prevention 2008 (update), www.ginasthma.org; 2008.
  5. British Guideline on the Management of Asthma; British Thoracic Society Scottish Intercollegiate Guidelines Network Thorax 2008; 63 (Supplement 4): 1-121.
  6. Barnes PJ. Corticosteoid effects on cell signalling. Eur Respir J. 2006;27:413–426
  7. Visser MJ, van der Veer E, Postma DS, et al. Side effects of fluticasone in asthmatic children: no effects after dose reduction. Eur Respir J. 2004;24:420–425
  8. Visser MJ, Postma DS, Arends LR. One-Year Treatment with Different Dosing Schedules of Fluticasone Propionate in Childhood Asthma. Am J Respir Crit Care Med. 2001;164:2073–2077
  9. Colice GL. New developments in inhaled corticosteroids. Allergy and Asthma. 2006;27:332–340
  10. Gulliver T, Morton R, Eid N. Inhaled corticosteroids in children with asthma: pharmacologic determinants of safety and efficacy and other clinical considerations. Pediatr Drugs. 2007;9:185–194
  11. Derendorf H, Nave R, Drollmann A, Cerasoli F, Wurst W. Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma. Review. Eur Respir J. 2006;28:1042–1050
  12. Brand PLP, Baraldi E, Bisgaard H, et al. Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. Eur Respir J. 2008;32:1096–1110
  13. Silverman M, Wang M, Hunter G, Taub N. Episodic viral wheeze in preschool children: effect of topical nasal corticosteroid prophylaxis. Thorax. 2003;58:431–434
  14. Panickar JR, Grigg J. Controversies in the management of preschool viral wheeze. Paediatric Respiratory Reviews. 2006;7:293–298
  15. Schokker S, Kooi EMW, Vries de RW, et al. Inhaled corticosteroids for recurrent respiratory symptoms in preschool children in general practice: randomized controlled trial. Pulm Pharmacol Ther. 2008;21:88–97
  16. Guilbert TW, Morgan WJ, Zeiger RS, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med. 2006;354(19):1985–1997
  17. Bisgaard H, Hermansen MN, Loland L, et al. Intermittent inhaled corticosteroids in infants with episodic wheezing. N Engl J Med. 2006;354:1998–2005
  18. The Childhood Asthma Management Program Research Group. Long-term Effects of Budesonide or Nedocromil in Children with Asthma. N Engl J Med 2008; 343: 1054-1063.
  19. van den Toorn LM, Overbeek SE, de Jongste JC, Leman K, Hoogsteden HC, Prins JB. Airway inflammation is present during clinical remission of atopic asthma. Am J Respir Crit Care Med. 2001; 164(11):2107-13. Erratum in: Am J Respir Crit Care Med. 2002; 166(8):1143.
  20. van den Toorn LM, Prins JB, de Jongste JC, et al. Benefit from anti-inflammatory treatment during clinical remission of atopic asthma. Respir Med. 2005;99(6):779–787
  21. Rasmussen FSHC, Lambrechtsen J, Hansen HS, Hansen NC. Impact of airway lability, atopy, and tobacco smoking on the development of asthma-like symptoms in asymptomatic teengares. Chest. 2000;117:1–9
  22. Plaschke P, Janson C, Norman E, Bjornsson E, Ellbjar S, Jarvholm B. Onset and remission of allergic rhinitis and asthma and the relationship with atopic sensitization and smoking. Am J Respir Crit Care Med. 2000;162:920–924
  23. Kerstjens H, Overbeek S, Schouten J, Brand P, Postma D. Airways hyperresponsiveness, bronchodilator response, allergy and smoking predict improvement in FEV1 during long-term inhaled budesonide. Eur Respir J. 1993;6:868–876
  24. Pedersen B, Dahl R, Karlstrom R, Peterson C, Venge P. Eosinophil and neutrphil activity in asthma in one-year trial with inhaled budesonide. Am J Respir Crit Care Med. 1996;153:1519–1529
  25. Chalmers GW, Macleod KJ, Little SA, Thomson LJ, McSharry CP, Thomson NC. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax. 2002;57:226–230
  26. Chaudhuri R, Livingston E, McMahon AD, Thomson L, Borland W, Thomson NC. Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. Am J Respir Crit Care Med. 2003;168:1308–1311
  27. Livingston E, Chaudhuri R, McMahon AD, Frase I, Mc Sharry CP, Thomson NC. Systemic sensitivity to corticosteroids in smokers with asthma. Eur Respi J. 2007;29:64–70
  28. Thomson NC, Chauderhuri R, Livingston E. Asthma and cigarette smoking. Review. Eur Respir J. 2004;24:822–833
  29. Peat JK, Woolcock AJ, Cullen K. rate of decline of lung function in subjects with asthma. Eur J Respir Dis. 1987;70:171–179
  30. Ulrik CS, Backer V, Dirksen A, et al. Extrinsic and intrinsic asthma from childhood to adult age: a 10-yr follow-up. Respir Med. 1995;89:547–554
  31. Dijkstra A, Vonk JM, Jongepier H, et al. Lung function decline in asthma: association with inhaled corticosteroids, smoking and sex. Thorax. 2006;61:105–110
  32. Lipworth BJ. Systemic adverse effects of inhaled corticosteroid therapy: a systemic review and meta-analysis. Arch Intern Med. 1999;159:941–955
  33. Allen DB. Effects of inhaled steroids on growth, bone metabolism, and adrenal function. Adv Pediatr. 2006;53:101–110
  34. Agertoft L, Pedersen S. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med. 2000;343:1064–1069
  35. Vries de TW, Roon van EN, Duiverman EJ. Inhaled corticosteroids do not affect behaviour. Acta Paediatr. 2008;97:786–789
  36. Gyllfors P, Dahlen SE, Kumlin M, Lasrsson K, Dahlen B. Bronchial responsiveness to leukotriene D4 is resistant to inhaled fluticasone prprionate. J Allergy Clin Immunol. 2006;118:78–83
  37. Straub DA, Minocchien S, Moeller A, et al. The effect of montelukast on exhaled nitric oxide and lung function in asthmatic children 2 to 5 years old. Chest. 2005;127:509–514
  38. Bisgaard H, Zielen S, Garcia-Garcia M, et al. Montelukast reduces asthma exacerbations in 2- to 5-year-old children with inetrmittent asthma. Am J Respir Crit Care Med. 2005;171:315–32237
  39. Bisgaard H, Flores-Nunez A, Goh A, et al. Study of montelukast for the treatment of respiratory symptoms of post-respiratory syncytial virus bronchiolitis in children. Am J Respir Crit Care Med. 2008;178(8):854–860
  40. Kooi EM, Schokker S, Boezen Marike H, et al. Fluticasone or montelukast for preschool children with asthma-like symptoms: randomized controlled trial. Pulm Pharmacol Ther. 2008;
  41. Joos S, Miksch A, Szecsenyi J, et al. Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review. Thorax. 2008;63(5):453–462
  42. Shinkai M, Henke MO, Rubin BK. Macrolide antibiotics as immunomodulatory medications: proposed mechanism of action. Pharm Therapeut. 2008;117:393–405
  43. Martin RJ, Kraft M, Chu HW, BErns EA, CAssell GH. A link between chronic asthma and chronic infection. J Allergy Clin Immunol. 2001;107:595–601
  44. Giamarellos-Bourboulis EJ. Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators. Int J Antimicr Agents. 2008;31(1):12–20
  45. Richeldi L, Ferrara G, FAbbri L, Lasserson TJ, Gibson PG. Macrolides for chronic asthma. Cochrane Database Syst Rev. 2005 Oct 19;(4):CD002997.
  46. The Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 2000; 343:1054-63.
  47. Rytila P, Pelkonen AS, Metso T, Nikander K, Haahtela T, Turpeinen M. Induced sputum in children with newly diagnosed mild asthma: The effect of 6 months of treatment with budesonide or disodium cromoglycate. Allergy. 2004;59(8):839–844
  48. Tasche MJ, Uijen JH, Bernsen RM, et al. Inhaled disodium cromoglycate (DSCG) as maintenance therapy in children with asthma: a systematic review. Thorax. 2000;55:913–920
  49. Hendeles L, Weinberger M. Theophylline use in asthma. Up to date; accessed Jan 6, 2009.
  50. Ito K, Lim S, Caramori G, Cosio B, Chung KF, Adcock IM, et al. A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression. Proc Natl Acad Sci U S A. 2002;99(13):8921–8926
  51. Guss S, Portnoy J. Methotrexate treatment of severe asthma in children. Pediatrics. 1992;89:635–639
  52. Coren ME, Rosenthal M, Bush A. The use of cyclosporin in corticosteroid dependent asthma. Arch Dis Child. 1997;77(6):522–523
  53. Holgate ST, Polosa R. Treatment strategies for allergy and asthma. Nature Rev Imm. 2008;8:218–230

PII: S1526-0542(09)00051-7

doi: 10.1016/j.prrv.2009.06.007

Paediatric Respiratory Reviews
Volume 10, Issue 4 , Pages 214-219 , December 2009

Article Tools

* Image Usage & Resolution